- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
VRIO Analysis of The Flaxil Label B
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of The Flaxil Label B will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The The Flaxil Label B VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The The Flaxil Label B VRIO Analysis shows that the financial resources of The Flaxil Label B are highly valuable as these help in investing into external opportunities that arise. These also help The Flaxil Label B in combating external threats.
- According to the VRIO Analysis of The Flaxil Label B, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The The Flaxil Label B VRIO Analysis shows that The Flaxil Label B's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of The Flaxil Label B's products.
- According to the VRIO Analysis of The Flaxil Label B, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for The Flaxil Label B. These patents also provide The Flaxil Label B with licensing revenue when it licenses these patents out to other manufacturers.
- The The Flaxil Label B VRIO Analysis shows that The Flaxil Label B’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for The Flaxil Label B. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of The Flaxil Label B, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The The Flaxil Label B VRIO Analysis shows that the research and development at The Flaxil Label B is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for The Flaxil Label B. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of The Flaxil Label B are found to be rare according to the VRIO Analysis of The Flaxil Label B. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by The Flaxil Label B VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as The Flaxil Label B and inhibit competitive advantage. This means that the local food products result in competitive parity for The Flaxil Label B. As this resource is valuable, The Flaxil Label B can still make use of this resource.
- The employees of The Flaxil Label B are a rare resource as identified by the VRIO Analysis of The Flaxil Label B. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of The Flaxil Label B are a rare resource as identified by the The Flaxil Label B VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows The Flaxil Label B to use them without interference from the competition.
- The distribution network of The Flaxil Label B is a rare resource as identified by the VRIO Analysis of The Flaxil Label B. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of The Flaxil Label B. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of The Flaxil Label B are costly to imitate as identified by the The Flaxil Label B VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of The Flaxil Label B. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by The Flaxil Label B provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of The Flaxil Label B are also not costly to imitate as identified by the The Flaxil Label B VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from The Flaxil Label B by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of The Flaxil Label B a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of The Flaxil Label B are very difficult to imitate as identified by the VRIO Analysis of The Flaxil Label B. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of The Flaxil Label B is also very costly to imitate by competition as identified by the The Flaxil Label B VRIO Analysis. This has been developed over the years gradually by The Flaxil Label B. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of The Flaxil Label B are organised to capture value as identified by the VRIO Analysis of The Flaxil Label B. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for The Flaxil Label B.
- The Patents of The Flaxil Label B are not well organised as identified by the The Flaxil Label B VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if The Flaxil Label B starts selling patented products before the patents expire.
- The distribution network of The Flaxil Label B is organised as identified by the VRIO Analysis of The Flaxil Label B. The Flaxil Label B uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for The Flaxil Label B.
From the VRIO Analysis of The Flaxil Label B, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of The Flaxil Label B is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Zaydon Lawrence
5.0
No doubt, good, really good assignment…Thankss!
Victor Karan
5.0
The work that I ordered here met all my requirements. Highly recommend this service and would like to recommend others to get help from here.
Euro Morris
5.0
Here were the features that I found satisfactory. The writer followed guidelines and made a paper that pleased the professor. Thanks!
Chelsea Connor
5.0
The assignment was on time. I always trust these guys for assignment writing and it never disappoints me. I’ll definitely recommend this company to my friends. Thank you!
Next Articles
- Jan Eriksson At Novartis Indonesia (A) Vrio Analysis
- Kurt Landgraf And Du Pont Merck Pharmaceutical Co. (B) Vrio Analysis
- Negotiating Partnerships In The Healthcare Industry (A): The Pharmac And Respire Deal Vrio Analysis
- Negotiating Partnerships In The Healthcare Industry (B): The Pharmac And Respire Deal Vrio Analysis
- Abbott And The AIDS Crisis (A) Vrio Analysis
- Treu Pharma: Role For Stef Kuehne Vrio Analysis
- China Novartis Institute For Biomedical Research: Building A Sustainable, Globally Integrated Research Enterprise Vrio Analysis
- Kevin Simpson Vrio Analysis
- Antegren: A Beacon Of Hope Vrio Analysis
- Terrapin Laboratory Vrio Analysis
Previous Articles
- Sms For Life (B): Living The Implementation Challenges Of A Successful Pilot Project Vrio Analysis
- Antegren: A Beacon Of Hope (C) Vrio Analysis
- Johnson & Johnson: Hospital Services Vrio Analysis
- Martha Goldberg Aronson: Challenges At Mid Career (B) Vrio Analysis
- MedCath Corporation (C) Vrio Analysis
- Consumer Driven Health Care: Medtronic's Health Insurance Options Vrio Analysis
- The Flaxil Label (A) Vrio Analysis
- The Paradox Of Pharmaceutical CSR: The Sincerity Nexus Vrio Analysis
- Merck & Company: Product KL 798 Vrio Analysis
- GLAXOSMITHKLINE AND AIDS DRUGS IN SOUTH AFRICA (C): THE FIGHT GOES ON Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!